U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07588698) titled 'Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma' on May 07.
Brief Summary: A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggressive B-cell non-Hodgkin lymphoma.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Non-Hodgkin's B-cell Lymphoma
Lymphoma Non-Hodgkin
Diffuse Large B-Cell Lymphoma (DLBCL)
Intervention:
DRUG: Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone (R-CHOP)
Given orally and intravenously (IV)
DRUG: Epcoritamab
Given subcutaneo...